French drugmaker Pierre Fabre will lean on XtalPi's AI and robotics platform to chase hard-to-drug cancer targets it has struggled…
GaiaBT is wiring AI drug design to external lab experiments, aiming to predict which patients will respond rather than just…
A Cambridge spinout betting on fully human T cell receptors has raised an oversubscribed Series B to move two programs…
A German-led team trained a survival model on 2,786 children and found many who could safely receive gentler radiation.
An orally available molecule designed to prise apart two cancer proteins gets its first clinical test after an AI-driven discovery…
A Brigham and Dana-Farber system of cooperating language models caught immune-related adverse events at F1 0.92 and halved annotation time…
Agendia presented clinical validation of a deep learning pipeline that infers MammaPrint risk categories from H&E whole-slide images at ESMO…
Insilico Medicine has banked an undisclosed milestone from Servier after nominating oncology targets and starting two programs.